GLOBAL CANCER TECHNOLOGY RECEIVES INITIAL PRE-CLINICAL RESULTS OF GCT-007 IN PSORIASIS
UNIVERSITY OF LOUISIANA AT MONROE, SCHOOL OF BASIC PHARMACEUTICAL & TOXICOLOGICAL SCIENCES EXPLORING GCT-007 FOR USE IN PSORIASIS SAN DIEGO, CALIFORNIA, UNITED STATES, October 18, 2023 /EINPresswire.com/ -- Global Cancer Technology, Inc. announced …